🔎 Trials Near Me

Akèy › Maladi Alzheimer

Etid klinik pou Maladi Alzheimer ap rekrite nan Etazini

236 etid pou Maladi Alzheimer ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 a 110 · Tout sèks · Mizajou Sep 30, 2026 · NCT07099053

DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

Ap rekriteFaz 1Volontè an sante akeyi
Laj 40 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07142278

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833

The Gut - PRO Study

Ap rekriteFaz 1Volontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07413744

Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease

Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 28, 2026 · NCT07794670

Dominantly Inherited Alzheimer Network (DIAN)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT00869817

A Study of LY3439539 in Participants With Alzheimer's Disease

Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370

Combating Alzheimer's Through Sleep and Exercise

Ap rekriteVolontè an sante akeyi
Laj 55 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT04855630

Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

Ap rekriteFaz 1/2
Laj 50 a 86 · Tout sèks · Mizajou Sep 23, 2026 · NCT07651319

Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation

Ap rekriteVolontè an sante akeyi
Laj 50 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT06094192

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07688213

Predicting Pre-dementia

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07516119

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

Music for Pain and Dementia

Ap rekrite
Laj 50 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07602283

Microbiome in Aging of Gut and Brain

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07799402

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05456503

Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05048966

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.